LIGAND PHARMACEUTICALS INCORPORATED Other Operating Income (Expense), Net
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Other Operating Income (Expense), Net of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherOperatingIncomeExpenseNet · last filed 2024-02-29
- LIGAND PHARMACEUTICALS INCORPORATED other operating income (expense), net for the quarter ending 2022-12-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED other operating income (expense), net for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED other operating income (expense), net for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED other operating income (expense), net for the quarter ending 2021-12-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED other operating income (expense), net for fiscal 2023 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED other operating income (expense), net for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- LIGAND PHARMACEUTICALS INCORPORATED other operating income (expense), net for fiscal 2021 was $37.60M.
- LIGAND PHARMACEUTICALS INCORPORATED other operating income (expense), net for fiscal 2020 was -$600.00K.
| Period end | Other Operating Income (Expense), Net 3 month | Other Operating Income (Expense), Net 6 month | Other Operating Income (Expense), Net 9 month | Other Operating Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $3.80M derived: sum of 2 quarters · filed 2024-02-29 | $37.90M derived: sum of 3 quarters · filed 2024-02-29 | $37.60M 10-K · filed 2024-02-29 |
| 2021-09-30 | $3.80M 10-Q · filed 2022-11-08 | $37.90M derived: sum of 2 quarters · filed 2022-11-08 | $37.60M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $34.10M 10-Q · filed 2022-08-09 | $33.80M 10-Q · filed 2022-08-09 | ||
| 2020-12-31 | -$600.00K 10-K · filed 2023-02-28 |